Response to the letter regarding "Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty" [0.03%]
关于“特立帕肽与阿仑膦酸钠治疗骨质疏松性骨折疗效 Meta 分析”的来信回复
Tatsuya Hosoi,Makoto Yunoki,Shiro Tanaka et al.
Tatsuya Hosoi et al.
Facial skin aging is a potential osteoporosis-associated marker: evidence from both observational and genetic studies [0.03%]
面部皮肤老化可能是与骨质疏松相关的标志：来自观察性和遗传学研究的证据
Zhi-Dan Yu,Hai-Bei Zang,Yun-Jie Zhu et al.
Zhi-Dan Yu et al.
Introduction: Facial skin aging (FSA) is a very easily observable indicator of aging, but whether FSA is associated with osteoporosis is still unknown. Ma...
Anabolic effects of Sost deficiency partially offset Opg deficiency-induced catabolism in cortical bone [0.03%]
Sost缺乏的同化作用部分抵消了Opg缺乏引起的皮质骨异化作用
Masanori Koide,Teruhito Yamashita,Yasuhiro Kobayashi et al.
Masanori Koide et al.
Introduction: Administration of an anti-sclerostin antibody enhances Wnt/β-catenin signaling, resulting in a significant increase in bone mass by stimulating bone formation and suppressing bone resorption. Wnt/β-catenin...
Treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis [0.03%]
接受维持性血液透析的骨质疏松症患者的Romosozumab治疗
Motohiko Sato
Motohiko Sato
Background: Dialysis patients are at increased risk of fractures, particularly in the proximal femur where cortical bone predominates. Effective treatments targeting cortical bone are therefore essential. Romosozumab is a...
Combining GNRI and CLR index predicts outcome following hip fracture surgery [0.03%]
GNRI和CLR指数联合预测髋部骨折术后预后
Jian Yuan Chua,Kuang-Ting Yeh,Ru-Ping Lee et al.
Jian Yuan Chua et al.
Introduction: Hip fractures in older adults lead to high mortality and reduced quality of life, requiring effective outcome prediction tools. The Geriatric Nutritional Risk Index (GNRI) evaluates nutritional status, while...
Comment on "Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty" [0.03%]
有关特立帕肽和阿仑膦酸在脆弱患者中抗骨折效果评价一文的述评
Huiyun Shi,Ruifeng Sun,Wei Sun
Huiyun Shi
Editorial comment [0.03%]
编者按
Toshio Matsumoto,Toshiyuki Yoneda
Toshio Matsumoto
Response to "Unhealthy lifestyles accelerated aging and consequential musculoskeletal morbidity: a critical appraisal" [0.03%]
对“不健康生活方式加速衰老及引发肌肉骨骼疾病”的评论文章回应
Hao-Long Zhou,Jiao-Jun Liang,Jonathan K L Mak et al.
Hao-Long Zhou et al.
Akihito Nishikawa,Naoyuki Kawao,Yuya Mizukami et al.
Akihito Nishikawa et al.
Introduction: Postmenopausal osteoporosis is a critical task in the clinical management of older individuals. Numerous studies have proposed various pathophysiological mechanisms for postmenopausal osteoporosis. Tmem119 i...
One-year bone mineral density gains with anti-osteoporotic medications and clinical factors associated with non-BMD gainers [0.03%]
抗骨质疏松症药物一年的骨密度获益及非骨密度获益患者的临床特征分析
Seol A Jang,Seok-Jae Heo,Su Jin Kwon et al.
Seol A Jang et al.
Introduction: Despite the increasing number of anti-osteoporotic medications for improving bone mineral density (BMD) and reducing fracture risk, some patients show unsatisfactory responses. ...